Phio Pharmaceuticals Corp. (PHIO)

Phio Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0	0	0	0	0	0.02
Revenue Growth (YoY)	-	-	-	-	-	-84.78%
Gross Profit	0	0	0	0	0	0.02
Selling, General & Admin	3.96	4.37	4.45	4.63	5.08	4.71
Research & Development	5.35	6.33	7.01	8.89	3.72	4.3
Other Operating Expenses	0.13	0.13	0	0	0	0
Operating Expenses	9.43	10.82	11.46	13.51	8.79	9.01
Operating Income	-9.43	-10.82	-11.46	-13.51	-8.79	-8.99
Interest Expense / Income	0	0	0	0	0	0
Other Expense / Income	-0.05	0	0.02	-0.22	-	-0.08
Pretax Income	-9.38	-10.83	-11.48	-13.29	-8.79	-8.91
Net Income	-9.38	-10.83	-11.48	-13.29	-8.79	-8.91
Shares Outstanding (Basic)	1	0	0	0	0	0
Shares Outstanding (Diluted)	1	0	0	0	0	0
Shares Change	300.98%	83.32%	6.30%	179.70%	895.43%	259.78%
EPS (Basic)	-29.25	-46.80	-90.90	-111.87	-207.36	-2087.64
EPS (Diluted)	-29.25	-46.80	-90.90	-111.87	-207.36	-2087.64
Free Cash Flow	-10.06	-10.75	-12.25	-11.91	-8.82	-8.72
Free Cash Flow Per Share	-19.76	-46.45	-97.00	-100.24	-207.67	-2043.01
Gross Margin	-	-	-	-	-	100.00%
Operating Margin	-	-	-	-	-	-42795.24%
Profit Margin	-	-	-	-	-	-42419.05%
Free Cash Flow Margin	-	-	-	-	-	-41509.52%
EBITDA	-9.21	-10.64	-11.29	-13.1	-8.61	-8.73
EBITDA Margin	-	-	-	-	-	-41580.95%
Depreciation & Amortization	0.17	0.18	0.19	0.19	0.18	0.18
EBIT	-9.38	-10.83	-11.48	-13.29	-8.79	-8.91
EBIT Margin	-	-	-	-	-	-42419.05%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).